-- Sanj K Patel, Director, Chairman & CEO, on May 01, 2026, sold 48,565 shares in Kiniksa Pharmaceuticals International (KNSA) for $2,623,481. Following the Form 4 filing with the SEC, Patel has control over a total of 237,763 Class A ordinary shares of the company, with 237,763 controlled indirectly.
SEC Filing: